StockWatch
·

Welspun Enterprises Ltd Q2 FY27 Results

WELENTQ2 FY27 Results
Filing
Result:Very Good· Market: Crashed#Broad based#Margin expansion

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.0K33.7%32.0%
Total Income1.1K33.0%33.9%
Expenditure723.885.4%6.9%
PBT351.71189.7%179.5%
Net Profit295.55424.4%201.3%
OPM37.10%17.65pp15.11pp
NPM27.48%20.51pp15.27pp
EPS21.71265.5%237.6%
View full financials

Core revenue grew 32% YoY with a sharp, broad-based margin expansion (OPM 22%→37.1%, NPM 12.2%→27.5%) driving adjusted PAT up 201%, a clear standout for an infra/EPC name with no disclosed one-off items.

WELSPUN ENTERPRISES · Q2 FY-2027 · THE VERDICT

The ₹194 Crore Quarter: Where Growth Really Sits

Welspun reported ₹296 Cr PAT and 32% growth that looks like a breakout—until you learn ₹194 Cr is a one-off stake sale. The real story: core growth is single-digit, H1 actual is 11% YoY (well below guidance), and management held full-year guidance steady rather than raising it.

13 Nov 2026 · 6 min read
Reported revenue

₹1,035 Cr

+32% YoY

One-off gain (Mukarba stake sale)

₹194 Cr

19% of revenue

Core revenue

~₹841 Cr

organic ops

Reported PAT

₹296 Cr

+201% YoY

One-off % of PAT

66%

₹194 Cr gain

Core PAT

~₹102 Cr

+8–10% YoY

On the result card it looks like a breakout: ₹1,035 crore revenue, ₹296 crore profit, margins at 39.5%. Yet the Q2 call revealed a quarter far more nuanced than the headline suggests. Management flagged early that the profit was heavily front-loaded: two-thirds of reported PAT came from the monetization of a 51% stake in Mukarba Chowk Panipat toll road. That ₹194 crore gain is real money and forms part of the company's capital-recycling strategy, but it masks the operational story. Core revenue was ~₹841 crore, core PAT ~₹102 crore. More telling: year-to-date through September, Welspun's organic revenue growth was only 11%, well below the 15% midpoint of its 10–20% FY27 guidance range.

The one-off math

Q2 FY27 revenue, ₹ Crore
0386.4772.81,159.21,035Reported194Mukarba one-off841Core revenue
The Mukarba stake sale inflates headline revenue by 19%. Core operations are the sustainable run rate.
Q2 FY27 PAT, ₹ Crore
0110.51221.01331.52296Reported PAT194One-off gain102Core PAT
Profit: the stake-sale gain is 66% of reported PAT. Core profit grew low single-digit YoY.

What the numbers say

H1 FY27 revenue stands at ₹1,808 crore, up 11% year-on-year. That's within the 10–20% guided band, but it sits well below the midpoint (15%), signaling the year is tracking toward the lower end. Management reiterated the guidance range with no uplift—a read that says: 'we're confident in the band, cautious on velocity.' The order book sits at ₹2,279 crore (as of Sept 30), providing roughly 18 months of revenue visibility at current run rates. However, concentration is an issue: the DGT oil & gas project with Adani accounts for ₹995 crore, or 44% of the total.

Management claims vs. what holds up

Q2 revenue ₹1,035 Cr, 32% YoY growth

Delivered ₹1,034.6 Cr; 32% growth real, but includes ₹194 Cr one-off. Core ops ~₹841 Cr.

Supported, with caveat

Q2 PAT ₹296 Cr, 201% YoY growth

Delivered ₹295.6 Cr; growth inflated by ₹194 Cr gain. Core PAT ~₹102 Cr, ~8–10% YoY.

Supported (headline), misleading

H1 revenue ₹1,808 Cr, 11% YoY; on track for guidance

Math checks out; 11% sits within 10–20% but below 15% midpoint. Q1 growth softer (~7–8% implied).

Supported

DGT order (₹995 Cr) covers ~3 years of revenue at current run rate

₹995 Cr ÷ annualized Q2 run rate (₹4,140 Cr) = ~9 months, not 3 years.

Overstated

Maintaining 18%+ EBITDA margin guidance

H1 macro EBITDA margin 33.7% (incl. one-offs); core margin ~20–22%, well above 18% floor.

Supported

What changed on this call

Management reverted FY27 revenue growth guidance from Q1's tighter 15% to the original 10–20% band—a widening that telegraphs caution. Two new catalysts came into focus: Aunta-Simaria road project divestment is now expected Q3 FY27 (₹200 crore equity value, plus ₹764 crore debt transfer), freeing capital. Pune-Shirur project's appointed date is now guided for Q4 FY27, with ₹300–400 crore revenue expected post-appointment in FY27, then ₹1,000–1,200 crore in FY28. The DGT oil & gas project with Adani has had its capital footprint trimmed by $300–400 million via reuse of existing offshore infrastructure—a favorable re-underwriting.

The bull-bear ledger
  • Order book ₹2,279 Cr; 18-month visibility with Pune-Shirur clarity

  • EBITDA margin 20–22% core, well above 18%+ guidance buffer

  • Aunta-Simaria & Mukarba divestments free capital for Pune-Shirur capex

  • Q2 profit 66% dependent on one-off; core PAT grows single-digit

  • H1 growth 11% trails 15% midpoint; trajectory softer than headline

  • WMEL ₹320 Cr H1 vs. ₹1,000 Cr full-year guide; 68% shortfall risk

  • DGT project 44% of order book; concentration and timing risk

  • Pune-Shirur capex financed (₹6,334 Cr committed); execution credible

Risks, ranked by holder concern

Top risks and why they matter

Pune-Shirur appointed date delay beyond Q4 FY27

High

Appointed date is the lynchpin for ₹300–400 Cr FY27 revenue recognition. Any slip into FY28 cascades into the ₹1,000–1,200 Cr FY28 ramp. Precon 70% done; test piling live; but large infrastructure projects slip frequently.

WMEL order-to-revenue conversion in H2

High

Division is ₹680 Cr short of its ₹1,000 Cr FY27 target. H2 needs ~70% catch-up to stay on track. If order releases slow or pricing compresses, full-year target and group guidance both risk missing.

Order-book concentration and DGT execution

Medium

DGT is ₹995 Cr of ₹2,279 Cr (44%). Management overstated it as ~3 years of revenue, but it's actually 9 months. If capex, regulatory approval, or production slips, order-book visibility shrinks materially.

Aunta-Simaria divestment slips to Q4 or FY28

Medium

Expected Q3 close would free ₹200 Cr equity capital and clean up ₹764 Cr debt. Close delays disrupt the capital-recycling narrative and earnings momentum. Multiple stakeholder approvals required.

Core margin compression from 20–22% to 18% floor

Low

Supply chain and execution cited as downside drivers. Current margin is healthy, but any shock (input costs, labor, TBM availability) could force guidance down.

How the street is positioned

The stock closed on November 12 at ₹710, trading above its 20-day SMA (₹671) but below its 50-day SMA (₹723)—a mixed technical setup. It sits 15.5% below its all-time high of ₹840, yet still +72% from its 52-week low of ₹412. RSI is neutral at 54.6; volume is increasing, a sign of potential re-engagement.

Ownership and recent flow signals
HolderLatest quarter stakeTrend
Promoter56.13%Stable
FII3.91%+45 bps (slight buying)
DII9.25%−8 bps (flat, near-stable)
Bulk activityAuthum sold ₹25L shares @ ₹765 on Sep 18Selling into strength (above current price)

FIIs are slowly accumulating (up 45 basis points this quarter), a modest vote of confidence. Authum Investment & Infrastructure sold 25 lakh shares at ₹765 on September 18—a price above today's ₹710—suggesting the bulk sale was near a recent peak and likely pre-earnings disclosure. However, the buyer for those shares (Fidelity Blue Chip Growth Fund) added stock the same day at ₹740.99, indicating active rotation rather than broad institutional disdain. The takeaway: the 15% drawdown from the all-time high and mixed technicals suggest the market has priced in near-term caution, but professional investors are still rotating into the stock ahead of catalysts.

What to watch next

Catalysts and key milestones
  • 1 · Aunta-Simaria divestment close (Q3 FY27 expected)

    If closed by December 2026, ₹200 Cr equity unlock plus ₹764 Cr debt transfer validates capital recycling and frees cash for Pune-Shirur. Any slip to Q4 or later signals deal-structure friction or approval delays.

  • 2 · Pune-Shirur appointed date (Q4 FY27, expected Feb–Mar 2027)

    Financial close and precon completion expected by March 2027. Post-appointment, ₹300–400 Cr FY27 revenue unlocks; FY28 ramp ₹1,000–1,200 Cr follows. Precon at 70%; test piling underway; slippage risk remains.

  • 3 · WMEL H2 order releases and revenue realization

    Division needs ₹680+ Cr in the next 6 months to hit ₹1,000 Cr FY27 target. Orders are 'released now, moving to convert'; execution and pricing will determine whether this bridge is crossed.

  • 4 · DGT project (EDP approval pending with DGH)

    Exploration & Development Plan submitted to Directorate General of Hydrocarbons; approval timing unclear. Capex reduction of $300–400 M already factored in. Any approval acceleration or further cost de-risk would be positive.

  • 5 · Q3 FY27 earnings (expected January 2027)

    Will confirm Aunta-Simaria one-off close or delay. Core ops momentum and order-book progression will signal confidence in FY28 ramp. WMEL ramp and pricing environment will be closely watched.

Welspun's Q2 delivered on every headline metric—revenue, margin, order book. But strip the ₹194 crore one-off and the quarter is a steady operational performance, not a step-change. Management's refusal to raise guidance despite strong reported numbers is the honest signal: core growth is moderate, catalysts are real but execution-dependent, and near-term momentum is softer than the ₹296 crore profit headline suggests.

The stock's 15% drawdown from its all-time high and mixed technicals suggest the market has already priced in near-term caution. For holders, the next 6 months are about catalyst execution: Aunta-Simaria close, Pune-Shirur appointed date, and WMEL's H2 ramp. For prospective buyers, wait for confirmation that these catalysts stick to the guidance timetable. The number to track from here is core PAT, not reported PAT—because one-offs are capital releases and wealth recycling, not repeatable earnings. If core PAT growth can hit 15%+ heading into FY28, the ₹1,000+ crore Pune-Shirur ramp will be the true inflection story. Until then, this is steady execution with optionality, not high conviction.

Informational and educational content only. Not investment advice.